查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1453996

注射細胞毒性藥物市場至2030年的預測：按藥物類型、分銷管道、應用和地區的全球分析

Injectable Cytotoxic Drugs Market Forecasts to 2030 - Global Analysis By Drug Type, Distribution Channel, Application, and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3個工作天內

價格

根據 Stratistics MRC 的資料，2023年全球注射細胞毒性藥物市場規模為 189 億美元，預計在預測期內將以 7.4%的年複合成長率成長，到2030年達到 311 億美元。

注射細胞毒性藥物是透過注射給藥的藥物，透過靶向和破壞快速分裂的癌細胞來治療各種癌症。這些藥物透過抑制細胞分裂過程、誘導細胞死亡和抑制腫瘤生長來發揮作用。它經常用於化療方案，包括胺基甲基葉酸、阿黴素和長春新鹼等藥物。儘管有副作用，注射細胞毒性藥物在癌症治療中非常重要，通常單獨使用或與其他治療方法合併使用，以縮小腫瘤、預防轉移並提高患者的存活率。

醫療保健支出增加

隨著醫療保健預算的擴大，獲得先進癌症治療方法（包括注射細胞毒性藥物）的機會也在增加。支出的增加將使醫療保健系統能夠為診斷為癌症的患者採購並提供更廣泛的治療選擇。此外，醫療保健設施設備齊全，可容納注射細胞毒性藥物的儲存、給藥和管理，進一步促進其在癌症治療方法中的使用，進一步推動該市場的發展。

開發成本高

新細胞毒性藥物的開發需要廣泛的臨床前研究、臨床試驗和監管部門的核准，而該過程的每一步都會產生巨大的成本，給製藥公司帶來了巨大的財務負擔。此外，獲得美國FDA和歐洲EMA等監管機構的核准並滿足監管要求會增加開發成本並阻礙市場開拓。

藥物開發的進展

藥物製劑技術的進步開發更穩定且生物可利用的細胞毒性藥物製劑，以改善藥物傳遞和組織滲透。這些進步涵蓋了藥物發現、配方和遞送的各個方面，並有助於開發更安全、更有效的細胞毒性療法。此外，這些方法使研究人員能夠識別對癌細胞具有增強選擇性和效力的化合物，同時最大限度地減少脫靶效應，有可能增加進一步推廣的市場潛力。

副作用和毒性

儘管這些藥物可以有效地針對快速分裂的癌細胞，但常常會產生副作用，影響患者的生活品質和治療依從性。注射細胞毒性藥物的常見副作用包括噁心、嘔吐、掉髮、疲勞和免疫抑制。此外，患者還可能因接觸細胞毒性藥物而出現長期併發症，例如繼發性癌症和器官損傷，這阻礙了市場的規模。

COVID-19 的影響

COVID-19 大流行對注射細胞毒性藥物市場產生了一些負面影響。全球醫療保健系統的中斷導致癌症篩檢、診斷和治療的延誤，導致患者數量下降。此外，封鎖、旅行限制和供應鏈中斷的後勤挑戰阻礙注射細胞毒性藥物的生產、分銷和交付。這進一步影響了患者獲得注射細胞毒性藥物的機會，特別是在資源有限的環境中，嚴重阻礙了這個市場。

長春花生物鹼預計將在預測期內成為最大的區隔

由於長春花生物鹼在癌症治療中的關鍵作用，估計其佔有率最大。這些藥物透過抑制微管形成來抑制細胞分裂並誘導快速分裂的癌細胞凋亡。此外，進行的研究和開發目的是最佳化長春花生物鹼的治療功效，同時最大限度地減少副作用，推動這一領域的擴張。

預計多發性硬化症領域在預測期內將經歷最高的年複合成長率

由於其顯著成長和技術創新，預計多發性硬化症領域在預測期內將出現最高的年複合成長率。干擾素BETA 1a 和干擾素BETA 1b 藥物有助於調節免疫系統的反應，減少多發性硬化症患者的發炎和復發頻率。此外，新的治療藥物，例如針對特定免疫途徑的單株抗體，日益擴大多發性硬化症患者的治療選擇，並推動該領域的成長。

佔有率最大的地區

由於北美癌症和多發性硬化症等自體免疫疾病的盛行率很高，因此全部區域對注射細胞毒性藥物的需求量很大。該地區受益於發達的醫療基礎設施、先進的醫療設施和高水準的醫療保健支出。此外，有利的償付政策和保險範圍有助於患者獲得這些基本藥物，支持該地區的擴張。

年複合成長率最高的地區：

由於歐洲擁有強大的製藥業、尖端研究和堅實的醫療基礎設施，預計在預測期內年複合成長率最高。在歐洲，學術界、工業界和監管機構之間的合作促進創新並加速研究成果的臨床轉化。此外，歐洲採用新的藥物傳輸技術，提高注射細胞毒性藥物的治療效果和安全性，進一步推動該地區的發展。

免費客製化服務：

訂閱此報告的客戶可以存取以下免費自訂選項之一：

  • 公司簡介
    • 其他市場參與者的綜合分析（最多3家公司）
    • 主要企業SWOT分析（最多3家公司）
  • 區域細分
    • 根據客戶興趣對主要國家的市場估計、預測和年複合成長率（註：基於可行性檢查）
  • 競爭基準化分析
    • 根據產品系列、地理分佈和策略聯盟對主要企業基準化分析

目錄

第1章 執行摘要

第2章 前言

  • 概述
  • 相關利益者
  • 調查範圍
  • 調查方法
    • 資料探勘
    • 資料分析
    • 資料檢驗
    • 研究途徑
  • 調查來源
    • 主要調查來源
    • 二次調查來源
    • 先決條件

第3章 市場趨勢分析

  • 促進因素
  • 抑制因素
  • 機會
  • 威脅
  • 應用分析
  • 新興市場
  • 新型冠狀病毒感染疾病（COVID-19）的影響

第4章 波特五力分析

  • 供應商的議價能力
  • 買方議價能力
  • 替代品的威脅
  • 新進入者的威脅
  • 競爭公司之間的敵對關係

第5章 全球注射細胞毒性藥物市場：依藥物類型

  • 長春花生物鹼
  • 細胞週期蛋白
  • 烷化劑
  • 紫杉烷
  • 抗代謝物
  • 鉑化合物
  • 其他藥物類型

第6章 全球注射細胞毒性藥物市場：按分銷管道

  • 零售藥房
  • 網路藥房
  • 醫院藥房
  • 癌症專科中心
  • 其他分銷管道

第7章 全球注射細胞毒性藥物市場：依應用分類

  • 腫瘤學
  • 多發性硬化症
  • 類風濕性關節炎
  • 其他用途

第8章 全球注射細胞毒性藥物市場：依地區

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 義大利
    • 法國
    • 西班牙
    • 其他歐洲國家
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 紐西蘭
    • 韓國
    • 其他亞太地區
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地區
  • 中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 卡達
    • 南非
    • 其他中東和非洲

第9章 主要進展

  • 合約、夥伴關係、協作和合資企業
  • 收購和合併
  • 新產品發布
  • 業務擴展
  • 其他關鍵策略

第10章 公司簡介

  • Merck & Co. Inc.
  • Pfizer, Inc.
  • F. Hoffmann-La Roche Ltd.
  • Amgen, Inc.
  • Bristol-Myers Squibb Company
  • Eli Lilly and Company
  • Sanofi
  • Johnson and Johnson Services Inc.
  • Abbie Inc
  • Novartis AG
Product Code: SMRC25548

According to Stratistics MRC, the Global Injectable Cytotoxic Drugs Market is accounted for $18.9 billion in 2023 and is expected to reach $31.1 billion by 2030 growing at a CAGR of 7.4% during the forecast period. Injectable cytotoxic drugs refer to medications administered via injection to treat various cancers by targeting and destroying rapidly dividing cancer cells. These drugs work by interfering with cell division processes, inducing cell death, or inhibiting tumor growth. Often used in chemotherapy regimens, they include agents like methotrexate, doxorubicin, and vincristine. Despite their side effects, injectable cytotoxic drugs are crucial in cancer treatment, often used alone or in combination with other therapies to shrink tumors, prevent metastasis, and improve patients' overall survival rates.

Market Dynamics:

Driver:

Increasing healthcare expenditure

As healthcare budgets expand, there's greater accessibility to advanced cancer treatments, including cytotoxic drugs administered via injection. This increased spending enables healthcare systems to procure and offer a wider range of treatment options to patients diagnosed with cancer. Moreover, healthcare facilities are better equipped to handle the storage, administration, and management of injectable cytotoxic drugs, further facilitating their use in cancer treatment regimens and propelling this market further.

Restraint:

High development costs

Developing a new cytotoxic drug involves extensive preclinical studies, clinical trials, and regulatory approvals, which incur significant expenses at each stage of the process and contribute to substantial financial burdens for pharmaceutical companies. Moreover, navigating regulatory requirements and obtaining approvals from regulatory agencies such as the FDA in the United States and the EMA in Europe adds to the development costs, thereby gradually impedes this market growth.

Opportunity:

Advancements in drug development

Advancements in drug formulation technologies have led to the development of more stable, bioavailable cytotoxic drug formulations that improve drug delivery and tissue penetration. These advancements encompass various aspects of drug discovery, formulation, and delivery, contributing to the development of safer, more efficacious cytotoxic therapies. Moreover, these approaches enable researchers to identify compounds with enhanced selectivity and potency against cancer cells while minimizing off-target effects, propelling this market further.

Threat:

Side effects and toxicity

These medications, while effective in targeting rapidly dividing cancer cells, often lead to adverse effects that impact patients' quality of life and treatment adherence. Common side effects of injectable cytotoxic drugs include nausea, vomiting, hair loss, fatigue, and immunosuppression. Moreover, patients may also develop long-term complications from cytotoxic drug exposure, including secondary cancers and organ damage, which hinder this market size.

Covid-19 Impact

The COVID-19 pandemic has had several negative impacts on the injectable cytotoxic drug market. Disruptions in healthcare systems worldwide have led to delays in cancer screenings, diagnoses, and treatments, resulting in a reduction in the number of patients. Furthermore, logistical challenges arising from lockdowns, travel restrictions, and supply chain disruptions have hampered the production, distribution, and delivery of injectable cytotoxic drugs. This has further impacted patient access to injectable cytotoxic drugs, particularly in resource-limited settings, which significantly hinders this market.

The vinca alkaloids segment is expected to be the largest during the forecast period

The vinca alkaloids segment is estimated to hold the largest share, due to its pivotal role in cancer treatment. These drugs work by disrupting microtubule formation, thereby inhibiting cell division and inducing apoptosis in rapidly dividing cancer cells. Additionally, ongoing research and development efforts aim at optimizing Vinca alkaloids' therapeutic benefits while minimizing adverse effects, thereby boosting this segment's expansion.

The multiple sclerosis segment is expected to have the highest CAGR during the forecast period

The multiple sclerosis segment is anticipated to have highest CAGR during the forecast period due to its significant growth and innovation. Interferon beta-1a and interferon beta-1b drugs help regulate the immune system's response, reducing inflammation and the frequency of relapses in MS patients. Moreover, emerging therapies, including monoclonal antibodies targeting specific immune pathways, are expanding treatment options for MS patients, which is driving this segment's growth.

Region with largest share:

North America commanded the largest market share during the extrapolated period, owing to the high prevalence of cancer and autoimmune diseases such as multiple sclerosis, there is a substantial demand for injectable cytotoxic drugs across the region. The region benefits from a well-established healthcare infrastructure, advanced medical facilities, and a high level of healthcare spending. Furthermore, favorable reimbursement policies and insurance coverage contribute to patients' access to these essential medications, propelling this region's expansion.

Region with highest CAGR:

Europe is expected to witness highest CAGR over the projection period, owing to the region's strong pharmaceutical industry, cutting-edge research, and robust healthcare infrastructure. Collaborative efforts between academia, industry, and regulatory agencies in Europe foster innovation and accelerate the translation of research findings into clinical practice. In addition, Europe has witnessed the adoption of novel drug delivery technologies, enhancing the therapeutic efficacy and safety profile of injectable cytotoxic drugs, which drives this region further.

Key players in the market

Some of the key players in the Injectable Cytotoxic Drugs Market include Merck & Co. Inc., Pfizer, Inc., F. Hoffmann-La Roche Ltd., Amgen, Inc., Bristol-Myers Squibb Company, Eli Lilly and Company, Sanofi, Johnson and Johnson Services Inc. , Abbie Inc, Novartis AG.

Key Developments:

In February 2024, Novartis announced that it has entered into an agreement to make a voluntary public takeover offer to acquire MorphoSys AG, a Germany-based, global biopharmaceutical company developing innovative medicines in oncology.

In July 2023, DTx Pharma, a preclinical stage biotechnology company addressing the delivery challenges of oligonucleotide therapeutics with its Fatty Acid Ligand Conjugated OligoNucleotide platform, announced that it has been acquired by Novartis.

Drug Types Covered:

  • Vinca Alkaloids
  • Anthracyclines
  • Alkylating Agents
  • Taxanes
  • Antimetabolites
  • Platinum Compounds
  • Other Drug Types

Distribution Channel Covered:

  • Retail Pharmacies
  • Online Pharmacies
  • Hospital Pharmacies
  • Specialty Cancer Centers
  • Other Distribution Channels

Applications Covered:

  • Oncology
  • Multiple Sclerosis
  • Rheumatoid Arthritis
  • Other Applications

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Application Analysis
  • 3.7 Emerging Markets
  • 3.8 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Injectable Cytotoxic Drugs Market, By Drug Type

  • 5.1 Introduction
  • 5.2 Vinca Alkaloids
  • 5.3 Anthracyclines
  • 5.4 Alkylating Agents
  • 5.5 Taxanes
  • 5.6 Antimetabolites
  • 5.7 Platinum Compounds
  • 5.8 Other Drug Types

6 Global Injectable Cytotoxic Drugs Market, By Distribution Channel

  • 6.1 Introduction
  • 6.2 Retail Pharmacies
  • 6.3 Online Pharmacies
  • 6.4 Hospital Pharmacies
  • 6.5 Specialty Cancer Centers
  • 6.6 Other Distribution Channels

7 Global Injectable Cytotoxic Drugs Market, By Application

  • 7.1 Introduction
  • 7.2 Oncology
  • 7.3 Multiple Sclerosis
  • 7.4 Rheumatoid Arthritis
  • 7.5 Other Applications

8 Global Injectable Cytotoxic Drugs Market, By Geography

  • 8.1 Introduction
  • 8.2 North America
    • 8.2.1 US
    • 8.2.2 Canada
    • 8.2.3 Mexico
  • 8.3 Europe
    • 8.3.1 Germany
    • 8.3.2 UK
    • 8.3.3 Italy
    • 8.3.4 France
    • 8.3.5 Spain
    • 8.3.6 Rest of Europe
  • 8.4 Asia Pacific
    • 8.4.1 Japan
    • 8.4.2 China
    • 8.4.3 India
    • 8.4.4 Australia
    • 8.4.5 New Zealand
    • 8.4.6 South Korea
    • 8.4.7 Rest of Asia Pacific
  • 8.5 South America
    • 8.5.1 Argentina
    • 8.5.2 Brazil
    • 8.5.3 Chile
    • 8.5.4 Rest of South America
  • 8.6 Middle East & Africa
    • 8.6.1 Saudi Arabia
    • 8.6.2 UAE
    • 8.6.3 Qatar
    • 8.6.4 South Africa
    • 8.6.5 Rest of Middle East & Africa

9 Key Developments

  • 9.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 9.2 Acquisitions & Mergers
  • 9.3 New Product Launch
  • 9.4 Expansions
  • 9.5 Other Key Strategies

10 Company Profiling

  • 10.1 Merck & Co. Inc.
  • 10.2 Pfizer, Inc.
  • 10.3 F. Hoffmann-La Roche Ltd.
  • 10.4 Amgen, Inc.
  • 10.5 Bristol-Myers Squibb Company
  • 10.6 Eli Lilly and Company
  • 10.7 Sanofi
  • 10.8 Johnson and Johnson Services Inc.
  • 10.9 Abbie Inc
  • 10.10 Novartis AG

List of Tables

  • Table 1 Global Injectable Cytotoxic Drugs Market Outlook, By Region (2021-2030) ($MN)
  • Table 2 Global Injectable Cytotoxic Drugs Market Outlook, By Drug Type (2021-2030) ($MN)
  • Table 3 Global Injectable Cytotoxic Drugs Market Outlook, By Vinca Alkaloids (2021-2030) ($MN)
  • Table 4 Global Injectable Cytotoxic Drugs Market Outlook, By Anthracyclines (2021-2030) ($MN)
  • Table 5 Global Injectable Cytotoxic Drugs Market Outlook, By Alkylating Agents (2021-2030) ($MN)
  • Table 6 Global Injectable Cytotoxic Drugs Market Outlook, By Taxanes (2021-2030) ($MN)
  • Table 7 Global Injectable Cytotoxic Drugs Market Outlook, By Antimetabolites (2021-2030) ($MN)
  • Table 8 Global Injectable Cytotoxic Drugs Market Outlook, By Platinum Compounds (2021-2030) ($MN)
  • Table 9 Global Injectable Cytotoxic Drugs Market Outlook, By Other Drug Types (2021-2030) ($MN)
  • Table 10 Global Injectable Cytotoxic Drugs Market Outlook, By Distribution Channel (2021-2030) ($MN)
  • Table 11 Global Injectable Cytotoxic Drugs Market Outlook, By Retail Pharmacies (2021-2030) ($MN)
  • Table 12 Global Injectable Cytotoxic Drugs Market Outlook, By Online Pharmacies (2021-2030) ($MN)
  • Table 13 Global Injectable Cytotoxic Drugs Market Outlook, By Hospital Pharmacies (2021-2030) ($MN)
  • Table 14 Global Injectable Cytotoxic Drugs Market Outlook, By Specialty Cancer Centers (2021-2030) ($MN)
  • Table 15 Global Injectable Cytotoxic Drugs Market Outlook, By Other Distribution Channels (2021-2030) ($MN)
  • Table 16 Global Injectable Cytotoxic Drugs Market Outlook, By Application (2021-2030) ($MN)
  • Table 17 Global Injectable Cytotoxic Drugs Market Outlook, By Oncology (2021-2030) ($MN)
  • Table 18 Global Injectable Cytotoxic Drugs Market Outlook, By Multiple Sclerosis (2021-2030) ($MN)
  • Table 19 Global Injectable Cytotoxic Drugs Market Outlook, By Rheumatoid Arthritis (2021-2030) ($MN)
  • Table 20 Global Injectable Cytotoxic Drugs Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 21 North America Injectable Cytotoxic Drugs Market Outlook, By Country (2021-2030) ($MN)
  • Table 22 North America Injectable Cytotoxic Drugs Market Outlook, By Drug Type (2021-2030) ($MN)
  • Table 23 North America Injectable Cytotoxic Drugs Market Outlook, By Vinca Alkaloids (2021-2030) ($MN)
  • Table 24 North America Injectable Cytotoxic Drugs Market Outlook, By Anthracyclines (2021-2030) ($MN)
  • Table 25 North America Injectable Cytotoxic Drugs Market Outlook, By Alkylating Agents (2021-2030) ($MN)
  • Table 26 North America Injectable Cytotoxic Drugs Market Outlook, By Taxanes (2021-2030) ($MN)
  • Table 27 North America Injectable Cytotoxic Drugs Market Outlook, By Antimetabolites (2021-2030) ($MN)
  • Table 28 North America Injectable Cytotoxic Drugs Market Outlook, By Platinum Compounds (2021-2030) ($MN)
  • Table 29 North America Injectable Cytotoxic Drugs Market Outlook, By Other Drug Types (2021-2030) ($MN)
  • Table 30 North America Injectable Cytotoxic Drugs Market Outlook, By Distribution Channel (2021-2030) ($MN)
  • Table 31 North America Injectable Cytotoxic Drugs Market Outlook, By Retail Pharmacies (2021-2030) ($MN)
  • Table 32 North America Injectable Cytotoxic Drugs Market Outlook, By Online Pharmacies (2021-2030) ($MN)
  • Table 33 North America Injectable Cytotoxic Drugs Market Outlook, By Hospital Pharmacies (2021-2030) ($MN)
  • Table 34 North America Injectable Cytotoxic Drugs Market Outlook, By Specialty Cancer Centers (2021-2030) ($MN)
  • Table 35 North America Injectable Cytotoxic Drugs Market Outlook, By Other Distribution Channels (2021-2030) ($MN)
  • Table 36 North America Injectable Cytotoxic Drugs Market Outlook, By Application (2021-2030) ($MN)
  • Table 37 North America Injectable Cytotoxic Drugs Market Outlook, By Oncology (2021-2030) ($MN)
  • Table 38 North America Injectable Cytotoxic Drugs Market Outlook, By Multiple Sclerosis (2021-2030) ($MN)
  • Table 39 North America Injectable Cytotoxic Drugs Market Outlook, By Rheumatoid Arthritis (2021-2030) ($MN)
  • Table 40 North America Injectable Cytotoxic Drugs Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 41 Europe Injectable Cytotoxic Drugs Market Outlook, By Country (2021-2030) ($MN)
  • Table 42 Europe Injectable Cytotoxic Drugs Market Outlook, By Drug Type (2021-2030) ($MN)
  • Table 43 Europe Injectable Cytotoxic Drugs Market Outlook, By Vinca Alkaloids (2021-2030) ($MN)
  • Table 44 Europe Injectable Cytotoxic Drugs Market Outlook, By Anthracyclines (2021-2030) ($MN)
  • Table 45 Europe Injectable Cytotoxic Drugs Market Outlook, By Alkylating Agents (2021-2030) ($MN)
  • Table 46 Europe Injectable Cytotoxic Drugs Market Outlook, By Taxanes (2021-2030) ($MN)
  • Table 47 Europe Injectable Cytotoxic Drugs Market Outlook, By Antimetabolites (2021-2030) ($MN)
  • Table 48 Europe Injectable Cytotoxic Drugs Market Outlook, By Platinum Compounds (2021-2030) ($MN)
  • Table 49 Europe Injectable Cytotoxic Drugs Market Outlook, By Other Drug Types (2021-2030) ($MN)
  • Table 50 Europe Injectable Cytotoxic Drugs Market Outlook, By Distribution Channel (2021-2030) ($MN)
  • Table 51 Europe Injectable Cytotoxic Drugs Market Outlook, By Retail Pharmacies (2021-2030) ($MN)
  • Table 52 Europe Injectable Cytotoxic Drugs Market Outlook, By Online Pharmacies (2021-2030) ($MN)
  • Table 53 Europe Injectable Cytotoxic Drugs Market Outlook, By Hospital Pharmacies (2021-2030) ($MN)
  • Table 54 Europe Injectable Cytotoxic Drugs Market Outlook, By Specialty Cancer Centers (2021-2030) ($MN)
  • Table 55 Europe Injectable Cytotoxic Drugs Market Outlook, By Other Distribution Channels (2021-2030) ($MN)
  • Table 56 Europe Injectable Cytotoxic Drugs Market Outlook, By Application (2021-2030) ($MN)
  • Table 57 Europe Injectable Cytotoxic Drugs Market Outlook, By Oncology (2021-2030) ($MN)
  • Table 58 Europe Injectable Cytotoxic Drugs Market Outlook, By Multiple Sclerosis (2021-2030) ($MN)
  • Table 59 Europe Injectable Cytotoxic Drugs Market Outlook, By Rheumatoid Arthritis (2021-2030) ($MN)
  • Table 60 Europe Injectable Cytotoxic Drugs Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 61 Asia Pacific Injectable Cytotoxic Drugs Market Outlook, By Country (2021-2030) ($MN)
  • Table 62 Asia Pacific Injectable Cytotoxic Drugs Market Outlook, By Drug Type (2021-2030) ($MN)
  • Table 63 Asia Pacific Injectable Cytotoxic Drugs Market Outlook, By Vinca Alkaloids (2021-2030) ($MN)
  • Table 64 Asia Pacific Injectable Cytotoxic Drugs Market Outlook, By Anthracyclines (2021-2030) ($MN)
  • Table 65 Asia Pacific Injectable Cytotoxic Drugs Market Outlook, By Alkylating Agents (2021-2030) ($MN)
  • Table 66 Asia Pacific Injectable Cytotoxic Drugs Market Outlook, By Taxanes (2021-2030) ($MN)
  • Table 67 Asia Pacific Injectable Cytotoxic Drugs Market Outlook, By Antimetabolites (2021-2030) ($MN)
  • Table 68 Asia Pacific Injectable Cytotoxic Drugs Market Outlook, By Platinum Compounds (2021-2030) ($MN)
  • Table 69 Asia Pacific Injectable Cytotoxic Drugs Market Outlook, By Other Drug Types (2021-2030) ($MN)
  • Table 70 Asia Pacific Injectable Cytotoxic Drugs Market Outlook, By Distribution Channel (2021-2030) ($MN)
  • Table 71 Asia Pacific Injectable Cytotoxic Drugs Market Outlook, By Retail Pharmacies (2021-2030) ($MN)
  • Table 72 Asia Pacific Injectable Cytotoxic Drugs Market Outlook, By Online Pharmacies (2021-2030) ($MN)
  • Table 73 Asia Pacific Injectable Cytotoxic Drugs Market Outlook, By Hospital Pharmacies (2021-2030) ($MN)
  • Table 74 Asia Pacific Injectable Cytotoxic Drugs Market Outlook, By Specialty Cancer Centers (2021-2030) ($MN)
  • Table 75 Asia Pacific Injectable Cytotoxic Drugs Market Outlook, By Other Distribution Channels (2021-2030) ($MN)
  • Table 76 Asia Pacific Injectable Cytotoxic Drugs Market Outlook, By Application (2021-2030) ($MN)
  • Table 77 Asia Pacific Injectable Cytotoxic Drugs Market Outlook, By Oncology (2021-2030) ($MN)
  • Table 78 Asia Pacific Injectable Cytotoxic Drugs Market Outlook, By Multiple Sclerosis (2021-2030) ($MN)
  • Table 79 Asia Pacific Injectable Cytotoxic Drugs Market Outlook, By Rheumatoid Arthritis (2021-2030) ($MN)
  • Table 80 Asia Pacific Injectable Cytotoxic Drugs Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 81 South America Injectable Cytotoxic Drugs Market Outlook, By Country (2021-2030) ($MN)
  • Table 82 South America Injectable Cytotoxic Drugs Market Outlook, By Drug Type (2021-2030) ($MN)
  • Table 83 South America Injectable Cytotoxic Drugs Market Outlook, By Vinca Alkaloids (2021-2030) ($MN)
  • Table 84 South America Injectable Cytotoxic Drugs Market Outlook, By Anthracyclines (2021-2030) ($MN)
  • Table 85 South America Injectable Cytotoxic Drugs Market Outlook, By Alkylating Agents (2021-2030) ($MN)
  • Table 86 South America Injectable Cytotoxic Drugs Market Outlook, By Taxanes (2021-2030) ($MN)
  • Table 87 South America Injectable Cytotoxic Drugs Market Outlook, By Antimetabolites (2021-2030) ($MN)
  • Table 88 South America Injectable Cytotoxic Drugs Market Outlook, By Platinum Compounds (2021-2030) ($MN)
  • Table 89 South America Injectable Cytotoxic Drugs Market Outlook, By Other Drug Types (2021-2030) ($MN)
  • Table 90 South America Injectable Cytotoxic Drugs Market Outlook, By Distribution Channel (2021-2030) ($MN)
  • Table 91 South America Injectable Cytotoxic Drugs Market Outlook, By Retail Pharmacies (2021-2030) ($MN)
  • Table 92 South America Injectable Cytotoxic Drugs Market Outlook, By Online Pharmacies (2021-2030) ($MN)
  • Table 93 South America Injectable Cytotoxic Drugs Market Outlook, By Hospital Pharmacies (2021-2030) ($MN)
  • Table 94 South America Injectable Cytotoxic Drugs Market Outlook, By Specialty Cancer Centers (2021-2030) ($MN)
  • Table 95 South America Injectable Cytotoxic Drugs Market Outlook, By Other Distribution Channels (2021-2030) ($MN)
  • Table 96 South America Injectable Cytotoxic Drugs Market Outlook, By Application (2021-2030) ($MN)
  • Table 97 South America Injectable Cytotoxic Drugs Market Outlook, By Oncology (2021-2030) ($MN)
  • Table 98 South America Injectable Cytotoxic Drugs Market Outlook, By Multiple Sclerosis (2021-2030) ($MN)
  • Table 99 South America Injectable Cytotoxic Drugs Market Outlook, By Rheumatoid Arthritis (2021-2030) ($MN)
  • Table 100 South America Injectable Cytotoxic Drugs Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 101 Middle East & Africa Injectable Cytotoxic Drugs Market Outlook, By Country (2021-2030) ($MN)
  • Table 102 Middle East & Africa Injectable Cytotoxic Drugs Market Outlook, By Drug Type (2021-2030) ($MN)
  • Table 103 Middle East & Africa Injectable Cytotoxic Drugs Market Outlook, By Vinca Alkaloids (2021-2030) ($MN)
  • Table 104 Middle East & Africa Injectable Cytotoxic Drugs Market Outlook, By Anthracyclines (2021-2030) ($MN)
  • Table 105 Middle East & Africa Injectable Cytotoxic Drugs Market Outlook, By Alkylating Agents (2021-2030) ($MN)
  • Table 106 Middle East & Africa Injectable Cytotoxic Drugs Market Outlook, By Taxanes (2021-2030) ($MN)
  • Table 107 Middle East & Africa Injectable Cytotoxic Drugs Market Outlook, By Antimetabolites (2021-2030) ($MN)
  • Table 108 Middle East & Africa Injectable Cytotoxic Drugs Market Outlook, By Platinum Compounds (2021-2030) ($MN)
  • Table 109 Middle East & Africa Injectable Cytotoxic Drugs Market Outlook, By Other Drug Types (2021-2030) ($MN)
  • Table 110 Middle East & Africa Injectable Cytotoxic Drugs Market Outlook, By Distribution Channel (2021-2030) ($MN)
  • Table 111 Middle East & Africa Injectable Cytotoxic Drugs Market Outlook, By Retail Pharmacies (2021-2030) ($MN)
  • Table 112 Middle East & Africa Injectable Cytotoxic Drugs Market Outlook, By Online Pharmacies (2021-2030) ($MN)
  • Table 113 Middle East & Africa Injectable Cytotoxic Drugs Market Outlook, By Hospital Pharmacies (2021-2030) ($MN)
  • Table 114 Middle East & Africa Injectable Cytotoxic Drugs Market Outlook, By Specialty Cancer Centers (2021-2030) ($MN)
  • Table 115 Middle East & Africa Injectable Cytotoxic Drugs Market Outlook, By Other Distribution Channels (2021-2030) ($MN)
  • Table 116 Middle East & Africa Injectable Cytotoxic Drugs Market Outlook, By Application (2021-2030) ($MN)
  • Table 117 Middle East & Africa Injectable Cytotoxic Drugs Market Outlook, By Oncology (2021-2030) ($MN)
  • Table 118 Middle East & Africa Injectable Cytotoxic Drugs Market Outlook, By Multiple Sclerosis (2021-2030) ($MN)
  • Table 119 Middle East & Africa Injectable Cytotoxic Drugs Market Outlook, By Rheumatoid Arthritis (2021-2030) ($MN)
  • Table 120 Middle East & Africa Injectable Cytotoxic Drugs Market Outlook, By Other Applications (2021-2030) ($MN)